TY - JOUR
T1 - Characterization of bovine lactoferrin nanoparticle prepared by desolvation technique
AU - Taguchi, Kazuaki
AU - Chuang, Victor Tuan Giam
AU - Hashimoto, Mai
AU - Nakayama, Mayuki
AU - Sakuragi, Mina
AU - Enoki, Yuki
AU - Nishi, Koji
AU - Matsumoto, Kazuaki
AU - Seo, Hakaru
AU - Otagiri, Masaki
AU - Yamasaki, Keishi
N1 - Funding Information:
Acknowledgment This work was supported by a Research Grant from the THE NAGAI FOUNDATION TOKYO, from Sojo University, from Keio University.
Publisher Copyright:
© 2020 The Pharmaceutical Society of Japan
PY - 2020
Y1 - 2020
N2 - Lactoferrin (Lf) nanoparticles have been developed as a carrier of drugs and gene. Two main methods, desolvation technique and emulsification method, for preparation of protein nanoparticles have been reported so far, but most of the previous reports of Lf nanoparticles preparation are limited to emulsification method. In this study, we investigated the optimal conditions by desolvation technique for the preparation of glutaraldehyde-crosslinked bovine Lf (bLf) nanoparticles within the size range of 100–200nm, and evaluated their properties as a carrier for oral and intravenous drug delivery. The experimental results of dynamic light scattering and Transmission Electron Microscope suggested that glutaraldehyde-crosslinked bLf nanoparticles with 150nm in size could be produced by addition of 2-propanol as the desolvating solvent into the bLf solution adjusted to pH 6, followed by crosslinking with glutaraldehyde. These cross-linked bLf nanoparticles were found to be compatible to blood components and resistant against rapid degradation by pepsin. Thus, cross-linked bLf nanoparticles prepared by desolvation technique can be applied as a drug carrier for intravenous administration and oral delivery.
AB - Lactoferrin (Lf) nanoparticles have been developed as a carrier of drugs and gene. Two main methods, desolvation technique and emulsification method, for preparation of protein nanoparticles have been reported so far, but most of the previous reports of Lf nanoparticles preparation are limited to emulsification method. In this study, we investigated the optimal conditions by desolvation technique for the preparation of glutaraldehyde-crosslinked bovine Lf (bLf) nanoparticles within the size range of 100–200nm, and evaluated their properties as a carrier for oral and intravenous drug delivery. The experimental results of dynamic light scattering and Transmission Electron Microscope suggested that glutaraldehyde-crosslinked bLf nanoparticles with 150nm in size could be produced by addition of 2-propanol as the desolvating solvent into the bLf solution adjusted to pH 6, followed by crosslinking with glutaraldehyde. These cross-linked bLf nanoparticles were found to be compatible to blood components and resistant against rapid degradation by pepsin. Thus, cross-linked bLf nanoparticles prepared by desolvation technique can be applied as a drug carrier for intravenous administration and oral delivery.
KW - Desolvation technique
KW - Lactoferrin
KW - Nanoparticle
UR - http://www.scopus.com/inward/record.url?scp=85088906472&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088906472&partnerID=8YFLogxK
U2 - 10.1248/CPB.C20-00222
DO - 10.1248/CPB.C20-00222
M3 - Article
C2 - 32741918
AN - SCOPUS:85088906472
SN - 0009-2363
VL - 68
SP - 766
EP - 772
JO - Chemical and Pharmaceutical Bulletin
JF - Chemical and Pharmaceutical Bulletin
IS - 8
ER -